Similar articles

• [Specular behavior of guanidine-dependent viral mutants in relation to the original sensitive strains].

  Maxia L, La Colla P, Schivo ML, Querzola F, Atzeni A. Maxia L, et al. Boll Soc Ital Biol Sper. 1970 Jan 15;46(1):23-7. Boll Soc Ital Biol Sper. 1970. PMID: 4315937 Italian. No abstract available.
• Double drug-dependence in a poliovirus strain.

  Marcialis MA, La Colla P, Sirigu F, Loddo B. Marcialis MA, et al. Ann Inst Pasteur (Paris). 1972 Oct;123(4):613-5. Ann Inst Pasteur (Paris). 1972. PMID: 4348600 No abstract available.
• Patterns of cytopathology and lysosomal enzyme release in poliovirus-infected HEp-2 cells treated with either 2-(alpha-hydroxybenzyl)-benzimidazole or guanidine HCl.

  Guskey LE, Smith PC, Wolff DA. Guskey LE, et al. J Gen Virol. 1970 Jan;6(1):151-61. doi: 10.1099/0022-1317-6-1-151. J Gen Virol. 1970. PMID: 4313397 No abstract available.
• The use of inhibitors in the study of picornavirus genetics.

  Sergiescu D, Horodniceanu F, Aubert-Combiescu A. Sergiescu D, et al. Prog Med Virol. 1972;14:123-99. Prog Med Virol. 1972. PMID: 4555915 Review. No abstract available.
• [Further data on genetic markers in polioviruses].

  Dinculescu E. Dinculescu E. Stud Cercet Inframicrobiol. 1971;22(3):231-60. Stud Cercet Inframicrobiol. 1971. PMID: 4331512 Review. Romanian. No abstract available.